ECSP982647A - COMBINATION THERAPY - Google Patents

COMBINATION THERAPY

Info

Publication number
ECSP982647A
ECSP982647A ECSP982647A ECSP982647A EC SP982647 A ECSP982647 A EC SP982647A EC SP982647 A ECSP982647 A EC SP982647A EC SP982647 A ECSP982647 A EC SP982647A
Authority
EC
Ecuador
Prior art keywords
combinations
atherosclerosis
hypertension
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robert Andrew Donald Scott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982647 priority Critical patent/ECSP982647A/en
Publication of ECSP982647A publication Critical patent/ECSP982647A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a combinaciones farmacéuticas de atarvastaina o una sal farmacéuticamente aceptable de la misma y agentes anthipertensores, estuches de ensayo que contienen dichas combinaciones y procedimientos para utilizar dichas combinaciones para tratar sujetos que sufren de angina pectoris, ateroesclerosis, hipertensión e hiperlipeidemia combinadas y para tratar sujetos que presentan síntomas de riesgo cardiaco, incluyendo seres humanos. Esta invención se refiere también a combinaciones aditivas y sinérgicas de atorvastatina o una sal farmacéuticamente aceptables de la mima y agentes antihipertensores por lo que estas combinaciones sinérgicas son útiles en el tratamiento de sujetos que sufren de angina pectoris, ateroesclerosis, hipertensión e hiperlipidemi combinadas y aquellos sujetos que presentan síntomas de riesgo cardiaco incluyendo los seres humanos.This invention relates to pharmaceutical combinations of atavastain or a pharmaceutically acceptable salt thereof and anthipertensive agents, test kits containing such combinations, and methods of using such combinations to treat subjects suffering from combined angina pectoris, atherosclerosis, hypertension, and hyperlipidemia, and to treat subjects presenting cardiac risk symptoms, including humans. This invention also relates to additive and synergistic combinations of atorvastatin or a pharmaceutically acceptable salt of mime and antihypertensive agents whereby these synergistic combinations are useful in the treatment of subjects suffering from combined angina pectoris, atherosclerosis, hypertension and hyperlipidemi and those subjects presenting symptoms of cardiac risk including humans.

ECSP982647 1998-08-28 1998-08-28 COMBINATION THERAPY ECSP982647A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982647 ECSP982647A (en) 1998-08-28 1998-08-28 COMBINATION THERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982647 ECSP982647A (en) 1998-08-28 1998-08-28 COMBINATION THERAPY

Publications (1)

Publication Number Publication Date
ECSP982647A true ECSP982647A (en) 1999-02-22

Family

ID=42043567

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982647 ECSP982647A (en) 1998-08-28 1998-08-28 COMBINATION THERAPY

Country Status (1)

Country Link
EC (1) ECSP982647A (en)

Similar Documents

Publication Publication Date Title
CO4970724A1 (en) COMBINATION THERAPY
CO4970694A1 (en) AMLODIPINE AND ATORVASTATINE USEFUL IN THE TREATMENT OF ANGINA BREAST, Atherosclerosis, hypertension and hyperlipidemia
CO4970726A1 (en) COMBINATION PINE AND ATORVASTATINE THERAPY USEFUL IN THE TREATMENT OF CHEST ANGINA, ATHEROSCLEROSIS, HYPERTENSION AND HYPERLIPIDEMIA
PT1014961E (en) TREATMENT OF ENXAQUECA ECHUSIA USING METOCLOPRAMIDE AND A NSAID
PT918774E (en) ANDROGENE RECEPTOR MODULATORS AND METHODS
NI200200095A (en) "PHARMACEUTICAL COMPOSITIONS OF AMLODIPINE AND ATORVASTATIN"
BR9908510A (en) Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease
PA8495701A1 (en) MUTUAL DRUGS OF AMLODIPINE AND ATORVASTATINE
DK1035859T3 (en) Use of phospholipid complexes from extracts of Vitis vinifera as anti-atherosclerotic agents
ECSP982647A (en) COMBINATION THERAPY
ECSP982645A (en) COMBINATION THERAPY
UY27510A1 (en) COMBINATION THERAPY
ECSP982646A (en) THERAPEUTIC COMBINATIONS
ECSP003497A (en) MUTUAL SALT OF AMLODIPINO AND ATORVASTATINA